Sector portfolio · Asset manager · United States
BlackRock's Biotech portfolio
BlackRock has backed 19 Biotech startups in rounds we track, $4.2B between them, shown by the stage each has reached. The best-funded is Kymera Therapeutics.
19startups backed
3stages
$4.2Braised between them
Series C and laterbiggest stage
Funding by segment
- Series C and later$2.1B8
- Stage not reported$1.1B7
- Series B$944M4
Where they are based
- United States16$3.7B
- Switzerland2$390M
- United Kingdom1$54M
United States
Switzerland
United KingdomFounded
1Earlier
12
313
114
115
216
417
218
319
20
21
22
23
24
25
26
2 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M0
- $10M to $50M2
- $50M to $250M12
- $250M to $1B5
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
17 of 19 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States16
- Switzerland2
- United Kingdom1
Startups by country, 3 countries in all.
Segment by segment
Series C and later
8 startups · $2.1B raised
Kymera TherapeuticsKymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.United States$799M
CellaresCellares is a biotechnology company based in South San Francisco, California, and is recognized as the world’s first Integrated DeUnited States$257M
Arcutis BiotherapeuticsArcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs.United States$245M
Science 37Science 37 is a clinical research company that facilitates universal participation in clinical trials for patients and providers.United States$236M
Decibel TherapeuticsDecibel Therapeutics is a hearing company focused on discovering and developing new medicines to protect, repair, and restore hearing.United States$189M
Vividion TherapeuticsWe are bringing more disease-causing targets within the reach of small molecule therapeutics to transform care for patients with dUnited States$185M
CellarityCellarity is a biotechnology therapeutics company based in Somerville, Massachusetts, founded in 2017 by Flagship Pioneering.United States$121M
Bright Peak TherapeuticsBright Peak Therapeutics is a private biotechnology company founded in 2017, with headquarters in Basel/Allschwil, Switzerland, anSwitzerland$90M
Stage not reported
7 startups · $1.1B raised
Taysha Gene TherapiesTaysha Gene Therapies develops treatments to eradicate severe and life-threatening monogenic diseases of the central nervous system.United States$400M
Monte Rosa TherapeuticsMonte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.Switzerland$300M
OnKure TherapeuticsOnKure is a clinical-stage biopharma company developing precision medicines targeting validated cancer drivers.United States$150M
CaresyntaxCaresyntax is a healthcare technology company founded in 2013, specializing in surgical intelligence.United States$144M
ElvieElvie is a femtech company that specializes in developing innovative technology to support women's health and wellness.United Kingdom$54M
Omega TherapeuticsOmega Therapeutics offers a proprietary epigenomic programming platform.United States$40M
MirvieMirvie is a biotechnology company based in South San Francisco, California, focused on improving pregnancy health through early deUnited States$24M
Series B
4 startups · $944M raised
LarondeLaronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body.United States$440M
SolugenDiscover the realm of digital intimacy where connections transcend physical boundaries.United States$246M
Annexon BiosciencesAnnexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders.United States$180M
TScan TherapeuticsTScan Therapeutics is a biopharmaceutical company focused on the development of immunotherapy treatments for cancer.United States$78M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names BlackRock as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosSector portfolioBlackRock's AI portfolio41 startups · $529BSector portfolioBlackRock's Fintech portfolio25 startups · $17BCo-investorsWho invests with BlackRock300 co-investorsPortfolio mapBlackRock portfolio map145 startups · $585BSector portfolioPerceptive Advisors' Biotech portfolio101 startups · $24BSector portfolioPerceptive Advisors' Pharma portfolio18 startups · $2.5B
Raising from investors like BlackRock?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.